ASNS on OTC
ACTELIS NETWORKS INC
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with UTStarcom, Maris Tech Ltd. or Knightscope, Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Regions
North America brought in 63% of the revenue ACTELIS NETWORKS INC broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| North America | $6.1M | $2.3M |
| Europe Middle East And Africa | $1.5M | $1.1M |
| Asia Pacific | $204.0K | $228.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue48¢$2.5M
- Research and development52¢$2.6M
Out of $3.7M in revenue.3 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| REVENUES | $3.7M | $7.8M |
| COST OF REVENUES | $2.5M | $3.5M |
| GROSS PROFIT | $1.2M | $4.3M |
| Research and development expenses | $2.6M | $2.4M |
| Sales and marketing expenses | $2.9M | $2.6M |
| General and administrative expenses | $2.9M | $3.2M |
| Other Income | -$163.0K | |
| TOTAL OPERATING EXPENSES | $8.4M | $8.0M |
| OPERATING LOSS | -$7.2M | -$3.8M |
| Interest expenses | -$251.0K | -$618.0K |
| Other financial (expense) income, net | -$825.0K | $2.0K |
| NET COMPREHENSIVE LOSS FOR THE YEAR | -$8.3M | -$4.4M |
| Net loss per share attributable to common shareholders basic (in Dollars per share) | -$5.68 | -$8.50 |
| Net loss per share attributable to common shareholders diluted (in Dollars per share) | -$5.68 | -$8.50 |
| Weighted average number of common stocks used in computing net loss per share basic (in Shares) | 1.5M shares | 514.6K shares |
| Weighted average number of common stocks used in computing net loss per share diluted (in Shares) | 1.5M shares | 514.6K shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2025-08-31 | 2024-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $4.1M | $2.0M | |
| Restricted cash equivalents | $305.0K | $300.0K | |
| Restricted bank deposit | $76.0K | ||
| Trade receivables, net of allowance for credit losses of $168 as of December 31, 2025, and December 31, 2024 respectively. | $1.1M | $1.6M | |
| Inventories | $2.5M | $2.4M | |
| Prepaid expenses and other current assets | $634.0K | $584.0K | |
| TOTAL CURRENT ASSETS | $8.6M | $6.9M | |
| Property and equipment, net | $26.0K | $38.0K | |
| Prepaid expenses | $459.0K | $492.0K | |
| Restricted bank deposits | $30.0K | $91.0K | |
| Severance pay fund | $264.0K | $205.0K | |
| Operating lease right of use assets | $69.0K | $410.0K | |
| Long-term deposits | $91.0K | $86.0K | |
| TOTAL NON-CURRENT ASSETS | $939.0K | $1.3M | |
| TOTAL ASSETS | $9.5M | $8.2M | |
| Credit lines | $479.0K | $774.0K | |
| Short term Loans | $350.0K | $400.0K | |
| Trade payables | $817.0K | $982.0K | |
| Deferred revenues | $223.0K | $246.0K | |
| Employee and employee-related obligations | $624.0K | $688.0K | |
| Accrued royalties | $612.0K | $673.0K | |
| Current maturities of operating lease liabilities | $14.0K | $415.0K | |
| Other current liabilities | $373.0K | $805.0K | |
| TOTAL CURRENT LIABILITIES | $3.5M | $4.6M | |
| Long-term loans, net of current maturities | $150.0K | $150.0K | |
| Deferred revenues | $20.0K | $92.0K | |
| Operating lease liabilities, net of current maturities | $23.0K | $6.0K | |
| Accrued severance | $292.0K | $229.0K | |
| Pre-funded Warrants Liability | $750.0K | ||
| Other long-term liabilities | $6.0K | $180.0K | |
| TOTAL NON-CURRENT LIABILITIES | $1.2M | $657.0K | |
| TOTAL LIABILITIES | $4.7M | $5.2M | |
| Common stock, value | $1.0K | $1.0K | |
| Additional paid-in capital | $57.1M | $47.0M | |
| Accumulated deficit | -$52.3M | -$44.1M | |
| TOTAL SHAREHOLDERS EQUITY | $4.8M | $3.0M | |
| TOTAL LIABILITIES AND SHAREHOLDERS EQUITY | $9.5M | $8.2M | |
| Trade receivables, net of allowance for credit losses | $168.0K | $168.0K | |
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in Shares) | 30.0M shares | 30.0M shares | |
| Common stock, shares issued (in Shares) | 8.1M shares | 762.3K shares | |
| Common stock, shares outstanding (in Shares) | 8.1M shares | 762.3K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss for the year | -$8.3M | -$4.4M |
| Depreciation | $20.0K | $26.0K |
| Changes in fair value related to warrants to lenders and investors | -$8.0K | |
| Inventory write-downs | $268.0K | $101.0K |
| Financial expenses (income) | $198.0K | -$24.0K |
| Share-based compensation | $309.0K | $337.0K |
| Issuance costs of ELOC agreement | $750.0K | |
| Trade receivables | $559.0K | -$952.0K |
| Net change in operating lease assets and liabilities | -$44.0K | $26.0K |
| Inventories | -$293.0K | -$11.0K |
| Prepaid expenses and other current assets | -$18.0K | -$143.0K |
| Trade payables | -$166.0K | -$787.0K |
| Deferred revenues | -$95.0K | -$122.0K |
| Other current liabilities | -$747.0K | -$580.0K |
| Other long-term liabilities | -$171.0K | -$38.0K |
| Net cash used in operating activities | -$7.7M | -$6.5M |
| Short term deposit | $1.0K | $198.0K |
| Purchase of property and equipment | -$9.0K | -$1.0K |
| Net cash provided by investing activities | -$8.0K | $197.0K |
| Proceeds from exercise of options | $32.0K | |
| Proceeds from issuance common stock - at the market offering (ATM) | $2.6M | $2.1M |
| Offering cost from issuance of common stock - at the market offering (ATM) | -$262.0K | -$125.0K |
| Proceeds from warrant inducement agreement | $1.6M | $5.2M |
| Underwriting commissions and other offering costs | -$193.0K | -$668.0K |
| Proceeds from issuance of common stocks and pre funded warrants September PIPE | $850.0K | |
| Offering cost from issuance of common stocks and pre funded warrants September PIPE | -$60.0K | |
| Proceeds from issuance of common stocks and warrants July PIPE | $1.0M | |
| Offering cost from issuance of common stock and warrants July PIPE | -$161.0K | |
| Proceeds from issuance of common stocks and warrants December Follow on | $5.0M | |
| Offering cost from issuance of common stock and warrants December Follow on | -$705.0K | |
| Proceeds from issuance common stock ELOC issuance | $56.0K | |
| Credit line, net | -$295.0K | $774.0K |
| Proceeds from short term loans | $750.0K | |
| Repayment of short term loans | -$400.0K | |
| Early repayment of long-term loan | -$4.0M | |
| Repayment of long-term loan | -$193.0K | |
| Net cash provided by financing activities | $9.8M | $3.1M |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | -$3.0K | $11.0K |
| INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | $2.1M | -$3.2M |
| Cash paid for interest | $348.0K | $624.0K |
| Right of use assets obtained in exchange for new operating lease liabilities | $33.0K | |
| Issuance costs of ELOC agreement | $750.0K | |
| Issuance costs of the Warrant inducement agreement and Warrant to underwriter | $3.0M | $2.7M |
| Warrant to lenders | $22.0K | $84.0K |
Recent filings
- Aug 25, 20268-K CURRENT REPORT
- Aug 13, 202610-Q QUARTERLY REPORT
- Aug 13, 20268-K CURRENT REPORT
- Jul 29, 20268-K CURRENT REPORT
- Jul 27, 20264
- Jul 16, 2026DEF 14A PROXY STATEMENT
- Jul 16, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS
- Jul 14, 202625-NSE
- Jul 13, 20268-K CURRENT REPORT
- Jul 13, 20263
- Jul 9, 2026SCHEDULE 13G
- Jul 8, 2026424B3 PROSPECTUS SUPPLEMENT
- Jul 7, 2026EFFECT
- Jul 6, 2026PRE 14A PRELIMINARY PROXY STATEMENT
- Jul 2, 2026EFFECT
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8